Just because something isn't listed in the 'risk factors' section of a company's regulatory filings doesn't mean it's not a possible 'risk'... Take DexCom (DXCM), for example. It's a wildly successful manufacturer of continuous glucose monitors ("CGMs"), which just happens to be headquartered not far from me here in San Diego.
Fascinating article. We've seen a lot of articles talking about how some pricey consumer staples stocks might come under pressure due to GLP-1s and biosimilars but not this company. Seems to be far more vulnerable than the multiple might suggest! Good luck & good trading.
Herb, being a father of a Type 1 diabetic (now 41 years old) , the Dexcom system is truly wonderful and truly a life saver as it gives a Type 1 the ability to monitor and control . But the use of a CGM on Type 2 whom is not swinging wildly and is marginal, these devices are total overkill. As soon as Dexcom combines a CGM with an insulin pump that is predictive, Type 1 s will have an artificial pancreas.
Thanks for the comment, John. If I were type 1 I couldn't imagine not using a CGM. Type 2 on insulin? Maybe? The big question here is whether the GLP-1s have impact on what they believe their true TAM really is. Will be fun to watch!
Or... maybe not... :)
https://seekingalpha.com/news/4009594-dexcom-stock-gains-cgm-use-rises-amid-weight-loss-therapy?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain
Early days!
Fascinating article. We've seen a lot of articles talking about how some pricey consumer staples stocks might come under pressure due to GLP-1s and biosimilars but not this company. Seems to be far more vulnerable than the multiple might suggest! Good luck & good trading.
Apple might be interested in DXCM, but there's a chance they become competitor also.
https://www.cnet.com/tech/mobile/apple-watch-series-9-rumors-will-it-get-a-blood-glucose-monitor/
Herb, being a father of a Type 1 diabetic (now 41 years old) , the Dexcom system is truly wonderful and truly a life saver as it gives a Type 1 the ability to monitor and control . But the use of a CGM on Type 2 whom is not swinging wildly and is marginal, these devices are total overkill. As soon as Dexcom combines a CGM with an insulin pump that is predictive, Type 1 s will have an artificial pancreas.
Thanks for the comment, John. If I were type 1 I couldn't imagine not using a CGM. Type 2 on insulin? Maybe? The big question here is whether the GLP-1s have impact on what they believe their true TAM really is. Will be fun to watch!